Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 2,7-disubstituted cephalosporin derivatives as beta-lactamase substrates and methods for their use for the diagnosis of tuberculosis

2,7-disubstituted cephalosporin derivatives as beta-lactamase substrates and methods for their use for the diagnosis of tuberculosis

US Patent 9834681 · Granted Dec 5, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Heteroaromatic acetamide derivative, and preparation and use thereof2025
Caspase-3-triggered molecular self-assembling PET probes and uses thereof2023
Caspase-3-triggered molecular self-assembling PET probes and uses thereof2023
Beta lactamase as biomarker for the specific detection of tuberculosis-complex b2021
6,7-trans cephalosporin-based probes for detecting bacteria expressing a metallo2020
Probes for rapid and specific detection of mycobacteria2019
Probes for rapid and specific detection of mycobacteria2019
2,7-disubstituted cephalosporin derivatives as β-lactamase substrates and method2019
2,7-disubstituted cephalosporin derivatives as β-lactamase substrates and method2019
2,7-disubstituted cephalosporin derivatives as β-lactamase substrates and method2019
2,7-disubstituted cephalosporin derivatives as β-lactamase substrates and method2019
Probe for imaging PARP-1 activity2019